
Opinion|Videos|August 14, 2024
Key Patient Factors Guiding Myelofibrosis Treatment Selection
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, outlines factors that inform treatment decisions for patients with myelofibrosis, including comorbidities and platelet count.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What are some specific patient factors that guide treatment selection in alignment with current NCCN guidelines?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
CGM prescribed by primary care lowers A1C and acute care use in diabetes patients
3
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
4
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
5
























